These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20010253)

  • 1. Aspirin for the prevention of cardiovascular disease: systematic review.
    Leaberry BA
    J Nurs Care Qual; 2010; 25(1):17-21. PubMed ID: 20010253
    [No Abstract]   [Full Text] [Related]  

  • 2. Late-breaking systematic reviews to inform evidence-based practice.
    Melnyk BM
    Worldviews Evid Based Nurs; 2010 Sep; 7(3):185-8. PubMed ID: 20456724
    [No Abstract]   [Full Text] [Related]  

  • 3. Evolving concepts in the primary prevention of cardiovascular disease: aspirin then and now.
    Hennekens CH; Bjorkman DJ
    Future Cardiol; 2014 Sep; 10(5):583-6. PubMed ID: 25354030
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of aspirin in cardiovascular disease prevention.
    Wagenaar P
    Cardiovasc J Afr; 2012 Jun; 23(5):300. PubMed ID: 23077735
    [No Abstract]   [Full Text] [Related]  

  • 5. Aspirin in the secondary prevention of cardiovascular disease.
    Parekh AK; Galloway JM; Hong Y; Wright JS
    N Engl J Med; 2013 Jan; 368(3):204-5. PubMed ID: 23323896
    [No Abstract]   [Full Text] [Related]  

  • 6. Aspirin for cardiovascular disease prevention.
    Janssen JH; Henshaw D
    Med J Aust; 2004 Jan; 180(2):94; author reply 94. PubMed ID: 14723595
    [No Abstract]   [Full Text] [Related]  

  • 7. Trials of primary prevention of cardiovascular events using aspirin.
    Kappagoda CT; Amsterdam EA
    Am J Cardiol; 2011 Oct; 108(8):1198-200. PubMed ID: 21985953
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevention of cardiovascular events with antiplatelet drugs: aspirin (and others)?].
    Patrono C
    Minerva Cardioangiol; 1999 Nov; 47(11):389-90. PubMed ID: 10641409
    [No Abstract]   [Full Text] [Related]  

  • 9. [Aspirin and primary prevention of cardiovascular diseases in the elderly].
    Manríquez M; Vallano A
    Rev Esp Geriatr Gerontol; 2009; 44(6):349-51. PubMed ID: 19726108
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary and secondary prevention of cardiovascular disease in diabetes with aspirin.
    Ajjan RA
    Diab Vasc Dis Res; 2012 Oct; 9(4):243-4. PubMed ID: 22942227
    [No Abstract]   [Full Text] [Related]  

  • 11. Would it be more beneficial to take aspirin in the evening for prevention of cardiovascular diseases?
    Kriszbacher I; Koppán M; Bódis J
    J Vasc Surg; 2005 Feb; 41(2):375. PubMed ID: 15768027
    [No Abstract]   [Full Text] [Related]  

  • 12. Aspirin in the primary prevention of cardiovascular disease.
    Galloway CF; Stevenson JC
    Maturitas; 2011 Jan; 68(1):3-4. PubMed ID: 21111550
    [No Abstract]   [Full Text] [Related]  

  • 13. Aspirin for the masses.
    Aslam F; Waheed A
    J Am Coll Cardiol; 2009 Jun; 54(1):91; author reply 91-2. PubMed ID: 19555850
    [No Abstract]   [Full Text] [Related]  

  • 14. Responses to USPSTF guideline on aspirin for prevention of cardiovascular disease.
    Mohan AV; Mohan CP; Balaban R
    Ann Intern Med; 2009 Oct; 151(8):587-8; author reply 588. PubMed ID: 19841461
    [No Abstract]   [Full Text] [Related]  

  • 15. Responses to USPSTF guideline on aspirin for prevention of cardiovascular disease.
    Budhraja V
    Ann Intern Med; 2009 Oct; 151(8):587; author reply 588. PubMed ID: 19841462
    [No Abstract]   [Full Text] [Related]  

  • 16. Rethinking Aspirin for the Primary Prevention of Cardiovascular Disease.
    Lin KW; Middleton J
    Am Fam Physician; 2019 Jun; 99(11):670-671. PubMed ID: 31150176
    [No Abstract]   [Full Text] [Related]  

  • 17. [Aspirin therapy for cardiovascular prevention in the diabetic patient: what have we learned from the evidence?].
    Legrand DA; Scheen AJ
    Rev Med Suisse; 2006 Aug; 2(76):1904-8. PubMed ID: 16972540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin for the primary prevention of cardiovascular events: recommendations and rationale.
    U.S. Preventive Services Task Force
    Am J Nurs; 2002 Mar; 102(3):67, 69-70. PubMed ID: 11976531
    [No Abstract]   [Full Text] [Related]  

  • 19. Should aspirin be used for the primary prevention of cardiovascular disease in the general population?
    Huang QY; Yang RQ
    Med Princ Pract; 2015; 24(2):198. PubMed ID: 25377538
    [No Abstract]   [Full Text] [Related]  

  • 20. Aspirin for primary prevention of cardiovascular disease (revisited).
    Med Lett Drugs Ther; 2006 Jul; 48(1238):53. PubMed ID: 16841021
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.